Agilon Health (NYSE:AGL) Announces Quarterly Earnings Results, Misses Expectations By $0.19 EPS

Agilon Health (NYSE:AGL) posted its earnings results on Wednesday. The company reported ($0.46) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.19), Zacks reports. Agilon Health had a negative net margin of 5.24% and a negative return on equity of 75.92%.

Here are the key takeaways from Agilon Health’s conference call:

• 2026 guidance: Management expects revenue around $5.5B (midpoint), medical margin ~$325M and adjusted EBITDA roughly breakeven at the midpoint, with platform membership targeted at 525k–540k (MA ~430k, ACO ~103k) and a net cost-trend assumption near 7%.
• Operational progress includes an enhanced data pipeline (member-level risk scoring covering >85% of members), AI-assisted Burden of Illness identification, and clinical pathways (CHF active in >90% of the network) that management says will improve risk capture, utilization and quality.
• 2025 financials were weak—full-year adjusted EBITDA of -$296M and medical margin of -$57M—driven by elevated cost trends (~6.5%) and several large inpatient claims, leading the company to exit unprofitable payer contracts and reduce MA membership (to ~430k, including ~25k on care-coordination fee arrangements).
• Liquidity and policy outlook: year-end cash of $285M (plus $91M ACO-held cash) with an extended credit facility and a plan to finish 2026 with at least $125M, while management warns the CMS Advance Notice may understate cost trends but believes its BOI/clinical initiatives can mitigate much of the risk-model impact.

Agilon Health Trading Up 31.0%

AGL stock traded up $0.12 during trading hours on Wednesday, hitting $0.52. 11,649,776 shares of the stock traded hands, compared to its average volume of 7,832,561. The stock has a 50-day simple moving average of $0.72 and a 200 day simple moving average of $0.86. The company has a market cap of $214.07 million, a P/E ratio of -0.69 and a beta of 0.06. Agilon Health has a one year low of $0.34 and a one year high of $6.08.

Key Stories Impacting Agilon Health

Here are the key news stories impacting Agilon Health this week:

• Neutral Sentiment: Company released quarterly results and published its press release and slide deck (Feb. 25). Investors can review the filings and presentation for management commentary and any updated guidance. View Press Release
• Negative Sentiment: Earnings missed analyst expectations: Agilon reported EPS of ($0.46) vs. consensus ($0.27), missing by $0.19. The release showed a negative net margin (~5.24%) and a deeply negative ROE (~-75.9%), underscoring continued profitability and execution challenges. These results explain investor concern and help justify increased trading volume. Earnings Press Release & Slides
• Negative Sentiment: Numerous law firms have filed investor alerts and class‑action notices alleging securities fraud tied to Agilon and are soliciting lead‑plaintiff candidates; the common class period cited is Feb. 26, 2025–Aug. 4, 2025 and the lead‑plaintiff deadline is March 2, 2026. The volume of notices (Rosen, Glancy, Levi & Korsinsky, Faruqi, Pomerantz, Bragar, and others) increases legal risk and creates a persistent overhang that can suppress the stock until resolution or clearer disclosure. Rosen Law Firm Notice

Hedge Funds Weigh In On Agilon Health

Hedge funds have recently made changes to their positions in the business. AQR Capital Management LLC lifted its stake in Agilon Health by 243.3% during the first quarter. AQR Capital Management LLC now owns 501,440 shares of the company’s stock valued at $2,171,000 after purchasing an additional 355,365 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Agilon Health by 3.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock valued at $927,000 after buying an additional 7,209 shares in the last quarter. Dynamic Technology Lab Private Ltd lifted its position in shares of Agilon Health by 28.4% during the 1st quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock valued at $204,000 after acquiring an additional 10,424 shares during the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Agilon Health by 6.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 5,060,333 shares of the company’s stock valued at $21,911,000 after acquiring an additional 311,158 shares during the last quarter. Finally, Creative Planning boosted its stake in shares of Agilon Health by 17.6% during the 2nd quarter. Creative Planning now owns 170,969 shares of the company’s stock worth $393,000 after acquiring an additional 25,548 shares in the last quarter.

Analysts Set New Price Targets

AGL has been the topic of several analyst reports. Royal Bank Of Canada upgraded Agilon Health from a “hold” rating to a “moderate buy” rating in a research report on Wednesday, December 3rd. Barclays lowered their price target on Agilon Health from $1.50 to $1.00 and set an “underweight” rating on the stock in a report on Thursday, November 6th. BTIG Research reaffirmed a “neutral” rating on shares of Agilon Health in a report on Friday, December 12th. Wells Fargo & Company decreased their target price on shares of Agilon Health from $1.50 to $1.00 and set an “overweight” rating for the company in a research report on Wednesday, November 5th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Agilon Health in a research report on Wednesday, January 21st. Four investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $2.71.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.